Security key
09075P105
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 27,093,277
- Total 13F shares
- 4,695,186
- Share change
- +4,695,186
- Total reported value
- $47,920,000
- Price per share
- $10.24
- Number of holders
- 22
- Value change
- +$47,920,000
- Number of buys
- 22
Report period
Q1 2018
Institutions
22
Top holders
10
BTAI full security history
Newer quarter: Q2 2018
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P105
Recent filing periods:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q1 2018
As of 31 Mar 2018,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,695,186 shares.
The largest 10 holders included
FMR LLC, Artemis Investment Management LLP, BARCLAYS PLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, VANGUARD GROUP INC, ASCEND CAPITAL, LLC, Monashee Investment Management LLC, Marshall Wace North America L.P., Point72 Asset Management, L.P., and Dean Capital Investments Management, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2018 holders
22
Holder diff
21
| Investor | Q3 2025 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.